These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2894161)

  • 1. Dose and concentration-effect relations for rilmenidine.
    Dollery CT; Davies DS; Duchier J; Pannier B; Safar ME
    Am J Cardiol; 1988 Feb; 61(7):60D-66D. PubMed ID: 2894161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats.
    Koenig-Berard E; Tierney C; Beau B; Delbarre G; Lhoste F; Labrid C
    Am J Cardiol; 1988 Feb; 61(7):22D-31D. PubMed ID: 2894153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.
    de Visser SJ; van Gerven JM; Schoemaker RC; Cohen AF
    Br J Clin Pharmacol; 2001 May; 51(5):423-8. PubMed ID: 11421999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced hemodynamic responses to physical and mental stress under low-dose rilmenidine in healthy subjects.
    Teixeira de Castro RR; Tibiriçá E; de Oliveira MA; Moreira PB; Catelli MF; Rocha NN; Nóbrega AC
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):129-34. PubMed ID: 16761192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rilmenidine and vigilance. Review of clinical studies.
    Mahieux F
    Am J Med; 1989 Sep; 87(3C):67S-72S. PubMed ID: 2571296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the sympathoinhibitory effect of rilmenidine mediated by alpha-2 adrenoceptors or imidazoline receptors?
    Urban R; Szabo B; Starke K
    J Pharmacol Exp Ther; 1994 Aug; 270(2):572-8. PubMed ID: 7915315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of the alpha 2-adrenoceptor agonist rilmenidine.
    Van Zwieten PA
    Am J Cardiol; 1988 Feb; 61(7):6D-14D. PubMed ID: 2894160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current data on the pharmacology of rilmenidine].
    Montastruc JL; Macquin-Mavier I; Damase-Michel C; Dard B; Tran MA; Valet P
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():25-9. PubMed ID: 2517006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-effect relationships of two rilmenidine single-dose infusion rates in hypertensive patients.
    de Visser SJ; van der Post JP; Nanhekhan L; Schoemaker RC; Cohen AF; van Gerven JM
    Clin Pharmacol Ther; 2002 Oct; 72(4):419-28. PubMed ID: 12386644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
    Harron DW; Hasson B; Regan M; McClelland RJ; King DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S48-54. PubMed ID: 8642806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.
    Weerasuriya K; Shaw E; Turner P
    Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and electrophysiologic effects of a new alpha 2-adrenoceptor agonist, rilmenidine, for systemic hypertension.
    Zannad F; Aliot E; Florentin J; Saulnier JP; Gilgenkrantz JM
    Am J Cardiol; 1988 Feb; 61(7):67D-71D. PubMed ID: 2894162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rilmenidine (S 3341) and the sympathoadrenal system: adrenoreceptors, plasma and adrenal catecholamines in dogs.
    Valet P; Tran MA; Damase-Michel C; de Saint-Blanquat G; Dang Tran L; Anglade F; Koenig-Berard E; Montastruc JL
    J Auton Pharmacol; 1988 Dec; 8(4):319-26. PubMed ID: 2908112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and tolerance of rilmenidine in patients with mild to moderate hypertension. Results of a Czech and Slovak 6-month multicenter study].
    Widimský J
    Vnitr Lek; 2002 Aug; 48(8):724-9. PubMed ID: 12425202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients.
    Galley P; Manciet G; Hessel JL; Michel JP
    Am J Cardiol; 1988 Feb; 61(7):86D-90D. PubMed ID: 2894166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine.
    Head GA; Burke S
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):819-26. PubMed ID: 1725893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.
    Lins RL; Daelemans R; Dratwa M; Verbeelen D; Sennesael J; Brisgand B; Lameire N
    Am J Med; 1989 Sep; 87(3C):41S-45S. PubMed ID: 2782326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-effect relationship of rilmenidine after chronic administration.
    Luccioni R; Lambert M; Ambrosi P; Scemama M
    Eur J Clin Pharmacol; 1993; 45(2):157-60. PubMed ID: 8223838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.